Experienced in Marfan Syndrome

Dr. Rohit R. Amin

Sacred Heart Health System Inc
Pensacola, FL
Experienced
in Marfan Syndrome
Specialties:Interventional Cardiology | Cardiology
Accepting New Patients
Offers Telehealth
OverviewInsuranceLocationsClinical Research

Overview

Rohit Amin is an Interventional Cardiologist and a Cardiologist in Pensacola, Florida. MD. Amin and is rated as an Experienced provider by MediFind in the treatment of Marfan Syndrome. His top areas of expertise are Necrosis, Heart Attack, Deep Vein Thrombosis, Embolectomy, and Thrombectomy. MD. Amin is currently accepting new patients.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Interventional Cardiology
Cardiology
Licenses
Internal Medicine in FL
Hospital Affiliations
Sacred Heart Hospital
Ascension Sacred Heart Bay
Baptist Hospital
Sacred Heart Hospital On The Emerald Coast
Santa Rosa Medical Center
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Health Options
  •  Humana
  •  Florida Blue

Locations

SACRED HEART HEALTH SYSTEM INC
2156 W Nine Mile Rd, Pensacola, FL 32534
850-416-2433
Other Locations
SACRED HEART HEALTH SYSTEM INC
4501 N Davis Hwy, Suite A, Pensacola, FL 32504
850-476-9000
SACRED HEART HEALTH SYSTEM INC
5151 N 9th Ave, Suite 200, Pensacola, FL 32504
850-416-4188
SACRED HEART HEALTH SYSTEM INC
36500 Emerald Coast Pkwy, Destin, FL 32541
850-416-1575
SACRED HEART HEALTH SYSTEM INC
550 Redstone W Ave, Crestview, FL 32536

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 3
A Prospective, Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class III Heart Failure Patients (PROACTIVE- HF Trial)
A Prospective, Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class III Heart Failure Patients (PROACTIVE- HF Trial)
Enrollment Status: Active_not_recruiting
Publish Date: February 16, 2024
Intervention Type: Device
Study Phase: Not Applicable
Barostim Neo® - Baroreflex Activation Therapy® for Heart Failure
Barostim Neo® - Baroreflex Activation Therapy® for Heart Failure
Enrollment Status: Unknown
Publish Date: January 23, 2023
Intervention Type: Drug, Device
Study Phase: Not Applicable
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure (CONNECT-HF)
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure (CONNECT-HF)
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Other
Study Phase: Not Applicable
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

5 Total Publications

Seated Pulmonary Artery Pressure Monitoring in Patients With Heart Failure: Results of the PROACTIVE-HF Trial.
Seated Pulmonary Artery Pressure Monitoring in Patients With Heart Failure: Results of the PROACTIVE-HF Trial.
Journal: JACC. Heart failure
Published: April 05, 2024

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile